![New Research Shows PSMA PET/CT Imaging Changes Management for Close to 50% of Prostate Cancer Patients | Imaging Technology News New Research Shows PSMA PET/CT Imaging Changes Management for Close to 50% of Prostate Cancer Patients | Imaging Technology News](http://www.itnonline.com/sites/default/files/Low-Res_Graphical%20Abstract%20Ng.jpg.png)
New Research Shows PSMA PET/CT Imaging Changes Management for Close to 50% of Prostate Cancer Patients | Imaging Technology News
![A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology](https://www.auajournals.org/cms/asset/3e9b0bb9-dff8-4dc9-a376-6265bd3e4176/abs-fig.jpg)
A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology
![A 57-year-old patient with serum PSA level 18 ng/ml and prostate volume... | Download Scientific Diagram A 57-year-old patient with serum PSA level 18 ng/ml and prostate volume... | Download Scientific Diagram](https://www.researchgate.net/publication/291015194/figure/fig5/AS:941406197657613@1601460136268/A-57-year-old-patient-with-serum-PSA-level-18ng-ml-and-prostate-volume-30cc-Left.jpg)
A 57-year-old patient with serum PSA level 18 ng/ml and prostate volume... | Download Scientific Diagram
Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program | PLOS ONE
![A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study - The Lancet Oncology A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/ce362f78-ae6e-4978-9907-9835e2914054/gr1_lrg.jpg)
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study - The Lancet Oncology
![JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study](https://www.mdpi.com/jcm/jcm-09-02308/article_deploy/html/images/jcm-09-02308-g001.png)